E
ZyVersa Therapeutics, Inc. ZVSA
$0.1221 -$0.0079-6.08% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -20.08% -18.50% -23.28% -17.73% -47.96%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -25.78% -24.13% -27.56% -21.81% -46.52%
Operating Income 25.78% 24.13% 27.56% 21.81% 46.52%
Income Before Tax 19.71% 20.16% 89.78% 17.28% 96.81%
Income Tax Expenses -- -- 99.50% -- 100.12%
Earnings from Continuing Operations 19.99% 20.16% 89.34% 17.27% 96.48%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 19.99% 20.16% 89.34% 17.27% 96.48%
EBIT 25.78% 24.13% 27.56% 21.81% 46.52%
EBITDA 25.77% 24.12% 27.46% 21.80% 46.55%
EPS Basic 86.12% 83.97% 98.85% 91.95% 99.80%
Normalized Basic EPS 86.07% 83.98% 91.35% 91.86% 96.73%
EPS Diluted 86.12% 83.97% 98.85% 91.95% 99.80%
Normalized Diluted EPS 86.07% 83.98% 91.35% 91.86% 96.73%
Average Basic Shares Outstanding 476.61% 398.22% 826.62% 915.83% 1,537.06%
Average Diluted Shares Outstanding 476.61% 398.22% 826.62% 915.83% 1,537.06%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --